Appeal In Reglan Preemption Row Blasted In Pa. High Court

Law360, Philadelphia (November 15, 2013, 6:09 PM EST) -- Thousands of plaintiffs in a cluster of product liability suits stemming from generic versions of the digestive drug Reglan urged the Pennsylvania Supreme Court on Thursday to deny the appeal of a July decision that their claims were not necessarily preempted by federal law.

Plaintiffs in some 2,300 coordinated suits tied to the drug said that the Pennsylvania Superior Court’s decision did not deal with a final order in the cases, but merely allowed a trial judge in Philadelphia County to conduct a state-by-state analysis to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.